Sirio Pharma has partnered with OmniActive Health Technologies to launch a pioneering soft chew lutein supplement, featuring the award-winning Lutemax 2020 extract. This innovative product will be showcased at Natural Products Expo West, taking place from March 4-6 in Anaheim, where attendees can sample the new offering at Booth 3434.
Lutemax 2020 is a patented extract that combines three essential macular carotenoids—lutein, RR-zeaxanthin, and RS (meso)-zeaxanthin—in a dietary ratio of 5:1. Derived from marigold flowers, this formulation is supported by clinical research demonstrating its health benefits. Given the rising concerns over eye health, particularly among the 46% of U.S. adults worried about their vision, the introduction of a soft chew format addresses a significant gap in the market, as only 2-4% of this demographic currently utilizes eye supplements.
The increasing prevalence of digital device usage has heightened the need for macular carotenoids, which are deemed conditionally essential nutrients. Lutemax 2020 has shown to enhance macular pigment density and serum lutein levels within eight weeks, improving visual performance metrics. The soft chew format allows for a higher ingredient load and an appealing consumer experience, contributing to a 41% sales increase in the U.S. soft chew market in 2024. This growth trajectory underscores the potential for Sirio Pharma’s new product to capture a larger share of the eye health supplement sector.
Doug Brown, VP Americas at Sirio Pharma, emphasized the importance of this partnership, stating that the Lutemax 2020 soft chews offer unique advantages in taste and manufacturing ease. With Sirio’s extensive experience in nutraceutical development and OmniActive’s commitment to scientific innovation, this collaboration is poised to meet the evolving demands of health-conscious consumers.
Open the full market picture for your next decision →
